Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus granulosus | fatty acid amide hydrolase 1 | 0.062 | 0.179 | 0.179 |
Plasmodium falciparum | lysophospholipase, putative | 0.014 | 0.0212 | 1 |
Mycobacterium tuberculosis | Possible lysophospholipase | 0.014 | 0.0212 | 0.0849 |
Echinococcus granulosus | fatty acid amide hydrolase 1 | 0.062 | 0.179 | 0.179 |
Plasmodium falciparum | esterase, putative | 0.014 | 0.0212 | 1 |
Mycobacterium leprae | POSSIBLE LYSOPHOSPHOLIPASE | 0.014 | 0.0212 | 1 |
Mycobacterium ulcerans | lysophospholipase | 0.014 | 0.0212 | 0.0834 |
Trypanosoma brucei | monoglyceride lipase, putative | 0.014 | 0.0212 | 1 |
Chlamydia trachomatis | glutamyl-tRNA(Gln) amidotransferase subunit A | 0.0075 | 0 | 0.5 |
Mycobacterium tuberculosis | 4,9-DHSA hydrolase | 0.0837 | 0.2501 | 1 |
Schistosoma mansoni | membrane associated proteins in eicosanoid and glutathione metabolism family member | 0.3123 | 1 | 1 |
Echinococcus multilocularis | fatty acid amide hydrolase 1 | 0.062 | 0.179 | 0.179 |
Trypanosoma brucei | monoglyceride lipase, putative | 0.014 | 0.0212 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.062 | 0.179 | 1 |
Trichomonas vaginalis | Clan SC, family S33, methylesterase-like serine peptidase | 0.014 | 0.0212 | 0.5 |
Trypanosoma cruzi | monoglyceride lipase, putative | 0.014 | 0.0212 | 1 |
Mycobacterium ulcerans | hypothetical protein | 0.014 | 0.0212 | 0.0834 |
Trichomonas vaginalis | Clan SC, family S33, methylesterase-like serine peptidase | 0.014 | 0.0212 | 0.5 |
Trichomonas vaginalis | Clan SC, family S33, methylesterase-like serine peptidase | 0.014 | 0.0212 | 0.5 |
Trichomonas vaginalis | Clan SC, family S33, methylesterase-like serine peptidase | 0.014 | 0.0212 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.014 | 0.0212 | 0.5 |
Entamoeba histolytica | hydrolase, alpha/beta fold family domain containing protein | 0.014 | 0.0212 | 0.5 |
Schistosoma mansoni | microsomal glutathione s-transferase | 0.3123 | 1 | 1 |
Schistosoma mansoni | fatty-acid amide hydrolase | 0.062 | 0.179 | 0.179 |
Treponema pallidum | aspartyl/glutamyl-tRNA amidotransferase subunit A | 0.0075 | 0 | 0.5 |
Plasmodium falciparum | lysophospholipase, putative | 0.014 | 0.0212 | 1 |
Leishmania major | monoglyceride lipase, putative | 0.014 | 0.0212 | 1 |
Mycobacterium ulcerans | 2-hydroxy-6-oxo-6-phenylhexa-2,4-dienoate hydrolase BphD | 0.0851 | 0.2545 | 1 |
Wolbachia endosymbiont of Brugia malayi | aspartyl/glutamyl-tRNA amidotransferase subunit A | 0.0075 | 0 | 0.5 |
Echinococcus multilocularis | fatty acid amide hydrolase 1 | 0.062 | 0.179 | 0.179 |
Trichomonas vaginalis | conserved hypothetical protein | 0.014 | 0.0212 | 0.5 |
Brugia malayi | amidase | 0.062 | 0.179 | 1 |
Toxoplasma gondii | MAPEG family protein | 0.3123 | 1 | 0.5 |
Trichomonas vaginalis | Clan SC, family S33, methylesterase-like serine peptidase | 0.014 | 0.0212 | 0.5 |
Echinococcus multilocularis | microsomal glutathione S transferase 3 | 0.3123 | 1 | 1 |
Plasmodium falciparum | lysophospholipase, putative | 0.014 | 0.0212 | 1 |
Entamoeba histolytica | hydrolase, alpha/beta fold family domain containing protein | 0.014 | 0.0212 | 0.5 |
Plasmodium vivax | PST-A protein | 0.014 | 0.0212 | 1 |
Schistosoma mansoni | amidase | 0.062 | 0.179 | 0.179 |
Trichomonas vaginalis | valacyclovir hydrolase, putative | 0.014 | 0.0212 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
GI50 (functional) | -4.958 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the HOP-92 Non-Small Cell Lung cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4.513 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the ACHN Renal cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4.283 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the HL-60(TB) Leukemia cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4.101 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the UO-31 Renal cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SN12C Renal cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the NCI-H23 Non-Small Cell Lung cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SF-539 Central Nervous System cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SK-MEL-5 Melanoma cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the MALME-3M Melanoma cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.